Researchers at Columbia University’s Herbert Irving Comprehensive Cancer Center are investigating a lung cancer treatment that can be delivered directly to the lungs.

The treatment, which involves the inhalation of interleukin-12 (IL-12) messenger RNA, uses nanobubbles to facilitate local delivery to the lungs with fewer off-target side effects.

Results of a preclinical study, published in Nature Nanotechnology, showed the approach has the ability to shrink tumors and prevent recurrence of lung carcinoma in mice… Continue reading.